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cbl-b Deficiency in Mice results in 
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Mice sensitized to ovalbumin (OVA) develop allergic airway disease (AAD) with short-term 
daily OVA aerosol challenge; inflammation resolves with long-term OVA aerosol expo-
sure, resulting in local inhalational tolerance (LIT). Cbl-b is an E3 ubiquitin ligase involved 
with CD28 signaling; Cbl-b−/− effector T cells are resistant to regulatory T cell-mediated 
suppression in vitro and in vivo. The present study utilized Cbl-b−/− mice to investigate 
the role of Cbl-b in the development of AAD and LIT. Cbl-b−/− mice exhibited increased 
airway inflammation during AAD, which failed to resolve with long-term OVA aerosol 
exposure. Exacerbation of inflammation in Cbl-b−/− mice correlated with increased 
proinflammatory cytokine levels and expansion of effector T cells in the BAL during AAD, 
but did not result in either a modulation of lymphocyte subsets in systemic tissues or in 
OVA-specific IgE in serum. These results implicate a role for Cbl-b in the resolution of 
allergic airway inflammation.
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inTrODUcTiOn
Mouse models of allergic airway disease (AAD) are important tools for investigating the underlying 
mechanisms of allergic asthma in humans. In both mice and humans, CD4+ T cells are essential for 
the initiation of airway inflammation in response to allergen exposure. These CD4+ T-helper type-2 
(TH2) cells are responsible for providing the proper signals for B cells to produce immunoglobulin 
type-E (IgE) antibodies, which are primary mediators of allergic responses through their interactions 
with receptors on mast cells. Additionally, TH2 T cells produce cytokines (e.g., IL-5) that are essential 
for eosinophil maturation and trafficking to the lung; these cells are hallmarks of allergic inflamma-
tion in both mice and humans. Therefore, elucidating the molecular mechanism(s) regulating CD4+ 
T cell activation is an important step toward developing clinical treatments for allergic asthma.
Efficient activation of T cells requires both T-cell receptor (TCR) ligation and costimulation, 
provided through interactions of T cell surface ligands (e.g., CD28 and ICOS) with correspond-
ing surface receptors on antigen-presenting cells (e.g., B7-1, B7-2, and ICOSL). In the absence of 
costimulation, TCR ligation results in functional inactivation of T cells, leading to T cell anergy and 
tolerance induction in vivo (1, 2). Therefore, the interactions of numerous costimulatory pathways 
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with TCR stimulation are essential for activation of T cells during 
an inflammatory response.
Negative regulators of costimulatory signal transduction 
proteins play an important role in T cell development and activa-
tion in vivo. One such regulator is the Casitas B cell lymphoma 
(Cbl) family of E3 ubiquitin ligases, which play an integral role 
in mediating TCR signal strength and subsequent survival and 
activation (3). Two family members, c-Cbl and Cbl-b, regulate 
TCR signal strength during positive and negative selection in 
the thymus, and in activation and survival in the periphery 
(4). Specifically, Cbl-b is important for mediating CD28 signal 
strength during TCR ligation, through negative control of the 
signal transduction proteins Vav1, PKCθ, and PLCγ (5–8). T 
cells lacking Cbl-b exhibit a decreased threshold of activation 
resulting in increased proliferative ability and increased IL-2 
production in vitro (9). Cbl-b plays an integral role in governing 
anergy induction in NK (10) and NK-T cells (11), and inhibi-
tion of Cbl-b expression or function in these cells can serve 
to enhance their anti-tumor activities. Cbl-b also negatively 
regulates B cell (12) and mast cell function (13). Mice deficient 
in Cbl-b develop spontaneous autoimmunity at advanced age, 
characterized by autoantibody production and infiltration of 
non-lymphoid organs by activated T and B cells (14); also, they 
have an increased propensity to develop experimentally induced 
autoimmunity [e.g., experimental autoimmune encephalomyeli-
tis (5)]. Additionally, Cbl-b T cells are resistant to regulatory T 
cell (Treg)-mediated suppression both in vivo and in vitro, as well 
as resistant to the immunosuppressive properties of transform-
ing growth factor-beta (TGF-β) (15, 16).
Ovalbumin (OVA)-induced AAD in mice generates a biphasic 
response whereby short-term aerosol challenge results in AAD, 
while long-term aerosol challenge results in a resolution of 
airway inflammation, referred to as local inhalational tolerance 
(LIT) (17). The induction of airway inflammation in response to 
OVA aerosol is critically dependent on TH2 cells (18). LIT may 
be mediated by Tregs, as cells with this phenotype are enriched 
in local lung compartments at timepoints correlating with the 
resolution of inflammation (19). As Cbl-b−/− T cells have been 
shown to exhibit a decreased activation threshold, and are resist-
ant to Treg-mediated suppression (15, 16), these mice provide 
a unique environment to study the role of CD4+ T cell–Treg 
interactions. A recent study has identified an important role for 
Cbl-b in mediating allergic inflammation, with Cbl-b−/− mice on a 
BALB/c background exhibiting enhanced TH2 and TH9 responses 
to OVA-induced AAD (20). This study implicates an important 
mechanistic role for Cbl-b in governing helper T cell responses to 
allergen through regulation of STAT6 and subsequent IL-4 pro-
duction; however, these studies did not directly address the effect 
of Cbl-b deficiency on T cell–Treg interactions in the context of 
allergic airway inflammation and the induction of LIT following 
chronic allergen exposure. Therefore, the purpose of this study 
was to determine if Cbl-b deficiency (Cbl-b−/− mice) had an effect 
the development of either the acute (inflammatory) stage or the 
chronic (resolution) stage of this OVA-induced model, and to 
determine if the modulated inflammatory response correlated 
with changes in Treg numbers or functions.
MaTerials anD MeThODs
animals
Female C57BL/6 mice, 3–4 months of age and weighing 15–20 g, 
were purchased from the Jackson Laboratory (Bar Harbor, ME, 
USA) and housed conventionally in plastic cages with corncob 
bedding. Cbl-b−/− mice harboring a global homozygous deletion 
of the Cbl-b gene were bred in the laboratory of Robert Clark, 
M.D., from breeding pairs originally obtained with permission 
from Hua Gu, Ph.D. (Columbia University College of Physicians 
and Surgeons, New York, NY, USA) (5). The animal room was 
maintained at 22–24°C with a daily light/dark cycle. Chow and 
water were supplied ad  libitum. The protocols for animal use 
were approved by the Animal Care Committee at the University 
of Connecticut Health Center.
Ovalbumin exposure Protocol
As previously described (17, 21), mice were immunized with three 
weekly intraperitoneal (i.p.) injections of a suspension containing 
25 μg of OVA (grade V, Sigma Chemical, St. Louis, MO, USA) and 
2 mg of aluminum hydroxide (alum) in 0.5 ml of 0.9% sodium 
chloride in sterile H2O (saline). One week after the last injection, 
the mice were exposed to 1% aerosolized OVA in 0.9% sodium 
chloride in sterile H2O (saline) for 1 h/day for either 7 (AAD) or 
42 days (LIT). The aerosols were generated by a BANG nebulizer 
(CH Technologies, Westwood, NJ, USA) into a 7.6  l nose-only 
inhalation exposure chamber to which individual restraint tubes 
were attached. Chamber airflow was 6 l/min, and aerosol particle 
size of OVA was monitored by gravimetric analysis with a Mercer 
cascade impactor (In-Tox Products, Moriarty, NM, USA). The 
mass median aerodynamic diameter and geometric SD were 
1.4 and 1.6 μm, respectively. The estimated daily inhaled OVA 
dose ~30–40 μg/mouse. Twenty-four hours after the final aerosol 
exposure, the mice were killed by ketamine/xylazine overdose 
and subsequent exsanguination.
Bronchoalveolar lavage/Tissue analysis
At sacrifice, local lung compartments such as bronchoalveolar 
lavage (BAL) fluid, lung tissue, and hilar lymph node (HLN) 
and systemic compartments such as inguinal lymph node (ILN) 
and spleens were harvested and processed for the isolation and 
enumeration of leukocytes. For collection of BAL, lungs were 
lavaged in situ with five 1 ml aliquots of 0.9% sodium chloride 
in sterile H2O (saline). The BAL fluid of wild-type and Cbl-b−/− 
mice at naïve, AAD and LIT timepoints were centrifuged, the 
cellular pellet washed, and total viable white blood cells (WBCs) 
were enumerated using a hemacytometer and vital dye exclusion 
(nigrosin) as a measure of viability. Cytospin preparations of BAL 
fluid were stained with May-Grunwald and Giemsa for cell differ-
ential analysis. Total eosinophils in BAL fluid were calculated by 
multiplying the percentages obtained by differential cell analysis 
by the total WBC count.
For the isolation of cells from lung tissue, mice were perfused 
with PBS/Heparin prior to dissection. Lungs were removed, 
minced, digested in collagenase (150 U/ml) (Invitrogen, Carlsbad, 
CA, USA), and the cellular suspension separated on a Percoll 
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(Sigma Chemical, St. Louis, MO, USA) density gradient for the 
isolation of lymphocytes. Lymph nodes and spleens were har-
vested and mechanically disrupted into a single-cell suspension. 
Hypotonic lysis with ammonium chloride lysis buffer (150 mM 
NH4Cl, 10 mM NaHCO3, 0.1 mM disodium EDTA in sterile H2O) 
was used to eliminate erythrocytes. For all tissue samples, total 
WBCs were obtained using a hemocytometer with nigrosin dye 
exclusion as a measure of viability.
Flow cytometry and immunofluorescence
Cells isolated from the BAL and other tissues were analyzed via 
flow cytometry using the following monoclonal antibodies: anti-
CD8a-FITC (53-6.7), anti-CD25-PE (PC61), anti-CD4-PeCy7 
(RM4-5), anti-CD3e-PerCP-Cy5.5. (145-2C11), and anti-CD19-
PerCP-Cy5.5 (1D3) (BD PharMingen, San Diego, CA, USA). 
Samples were washed in PBS containing 0.2% bovine serum albu-
min and 0.1% NaN3. Aliquots containing 104–106 cells were incu-
bated with 100 μl of appropriately diluted antibodies for 30 min 
at 4°C. After staining, the cells were washed with the above PBS 
solution, and relative fluorescence intensities were determined on 
a four-decade log scale by flow cytometric analysis using a LSR II 
(Becton-Dickinson, San Diego, CA, USA). For the identification 
of Treg, intracellular staining of Foxp3 protein was used. Briefly, 
cells stained with the antibodies mentioned previously (i.e., 
anti-CD3e, anti-CD4, and anti-CD25) were permeabilized using 
fixation/permeabilization buffer following the manufacturer’s 
protocol, and stained using either anti-Foxp3-FITC (FJK-16s) or 
anti-Foxp3-APC (FJK16s) with corresponding isotype controls, 
IgG2a-FITC or -APC (eBioscience, San Diego, CA, USA).
histology
After sacrifice, unmanipulated (not subject to BAL) and non-
inflated lungs from separate animals were removed and fixed with 
10% formalin. Preserved lungs were embedded in paraffin and 
tissue sections were prepared using a microtome and mounted 
onto glass slides. Mounted tissue sections were then stained with 
hematoxylin and eosin for standard evaluation, and periodic 
acid-Schiff (PAS) for evaluation of mucus production.
ige elisa
Ovalbumin-specific IgE levels were measured by ELISA using iso-
type-specific capture monoclonal antibodies following a standard 
protocol (22). Briefly, IgE was captured from diluted serum using 
Immulon 2 microtiter plates (Dynatech Laboratories, Chantilly, 
VA, USA) coated with anti-mouse IgE (R35-72; BD PharMingen, 
San Diego, CA, USA) at 2 μg/ml in 0.1 mol/l carbonate, pH 9.5. 
Detection was with an OVA-digoxigenin conjugate followed by 
horseradish peroxidase-conjugated anti-digoxigenin. Plates were 
developed with the TMB microwell peroxidase substrate system 
(Kirkegaard and Perry Laboratories, Gaithersburg, MD, USA).
Multiplex cytokine analysis
Concentrations of proinflammmatory cytokines in BAL fluid 
were measured using a mouse cytokine custom bead assay 
(Bio-Rad, Hercules, CA, USA) and analyzed using a Luminex 
Bio-Plex 200 system (Bio-Rad), according to the manufacturer’s 
protocol. Briefly, the 96-well multiplex assay plate was coated 
with anti–mouse cytokine conjugated beads for the capture of 
IL-2, IL-4, IL-5, IL-6, IL-10, IL-12p70, IL-13, IFN-γ, and CCL5 
(Eoxtaxin). Plates were rinsed two times with the provided wash 
buffer, standards and experimental samples were loaded, and 
the plate was incubated for 30  min at room temperature with 
gentle vortex. After three washings, the biotinylated mouse 
cytokine detection antibody was added for 30 min at room tem-
perature with gentle vortex. The plates were washed again, and 
PE-conjugated streptavidin was added for 10 min at room tem-
perature with gentle vortex. Plates were washed and read using 
the Luminex Bio-Plex 200 system plate reader according to the 
manufacturer’s instructions. Standard curves were generated by 
analysis of serially diluted samples of a known cytokine standard 
provided by the manufacturer. The threshold of detection of each 
cytokine is 5 pg/ml.
statistical analysis
Analysis of variance (ANOVA) followed by post hoc two-tailed 
Student’s unpaired t-tests were used for data analysis. All 
statistical analysis was performed using either the JMP IN 5.1 
statistical software package (SAS Institute, Cary, NC, USA) or 
the GraphPad Prism 4 software package (GraphPad Software, La 
Jolla, CA, USA).
resUlTs
cbl-b−/− Mice exhibit increased Bal WBcs 
and eosinophils During aaD and liT
Prior to sensitization and aerosol challenge, Cbl-b−/− mice had 
similar BAL cell composition as wild-type naive controls, consist-
ing primarily of macrophages (98.3 ± 0.5% WT and 96.1 ± 0.9% 
Cbl-b−/−). At AAD, Cbl-b−/− mice developed enhanced airway 
inflammation compared to wild-type controls, with a significant 
increase in total BAL leukocytes (p = 0.0016; Figure 1A) consist-
ing primarily of eosinophils (83.2 ± 1.6% WT and 82.1 ± 2.2% 
Cbl-b−/−). The total number of eosinophils in Cbl-b−/− BAL fluid 
at AAD was increased over twofold as compared to wild-type 
mice (p = 0.002; Figure 1B). At LIT, while both wild-type and 
Cbl-b−/− mice exhibited significant decreases in total BAL WBCs 
from their respective AAD levels (p <  0.05 for LIT vs. AAD) 
(Figure 1A), there remained a significant increase in total WBCs 
(over 4-fold; p = 0.046; Figure 1A) and eosinophils (over 12-fold; 
p = 0.030; Figures 1B,C) in the BAL of Cbl-b−/− mice as compared 
to wild-type mice.
cbl-b−/− Mice Demonstrated histological 
evidence of increased lung inflammation 
and Mucus Production During aaD 
and liT
Cbl-b−/− mice have an increased propensity to develop both spon-
taneous autoimmunity and experimentally induced autoimmune 
diseases (5, 14). To ensure that the lung histological observations 
seen in Cbl-b−/− mice were not due to pre-existing airway inflam-
mation prior to sensitization and aerosol challenge, lungs from 
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age-matched and older (18 weeks) Cbl-b−/− mice were analyzed for 
airway inflammation. Naïve wild-type (Figure 2A), naïve aged-
matched Cbl-b−/− (Figure  2B), and 18-week-old Cbl-b−/− lungs 
(data not shown) were comparable with little to no evidence of 
airway inflammation prior to sensitization and aerosol challenge.
At AAD, qualitative analysis of lungs from Cbl-b−/− mice 
showed increased perivascular and peribronchial inflammation 
(Figure 2D) as compared to wild-type mice (Figure 2C). Similar 
increases in mucus production (Figure 2D – insert) were seen for 
Cbl-b−/− mice as compared to wild-type mice (Figure 2C – insert), 
with significant mucus plugging apparent in the bronchial air-
ways. This increase in lung inflammation was striking at LIT, with 
significant perivascular and peribronchial inflammation persist-
ing in Cbl-b−/− mice (Figure 2F) as compared to the resolution 
of inflammation in wild-type mice (Figure  2E) in response to 
long-term aerosol challenge. Along with increased inflammation, 
Cbl-b−/− mice also showed evidence of mucus production in the 
airways at LIT (Figure 2F – insert), whereas wild-type mice had 
airways that were clear of mucus production (Figure 2E insert).
exacerbation of inflammation in cbl-b−/− 
Mice resulted in Modulation of the 
lymphocyte Populations in the hln at liT 
but not aaD
As Cbl-b mice exhibited increased airway inflammation and 
eosinophilia in response to aerosol challenge, we sought to 
FigUre 1 | Total white blood cells and eosinophils are increased in the Bal of cbl-b−/− mice at aaD and liT. (a) Total white blood cells (WBCs) in BAL 
fluid were enumerated using a hemacytometer and nigrosin stain for viability. (B,c) Cytokine preparations of BAL fluid from AAD (B) and LIT (c) mice were stained 
with May-Grunwald and Giemsa for cell differential analysis. Total eosinophils in BAL fluid were calculated by multiplying the percentages obtained by differential cell 
analysis by the total WBC count. Data represent the mean + SEM of 7–9 mice per group. *p < 0.05 vs. respective AAD or LIT wild-type mice.
determine if the total number and/or frequency of lymphocyte 
subsets in local (HLN) and systemic (ILN) tissues were affected 
as well. No significant differences were seen in percentages or 
total numbers of T or B cell subsets analyzed in the wild-type or 
Cbl-b−/− mice at naïve or sensitized timepoints (data not shown). 
At AAD, a similar pattern was observed, with no significant dif-
ferences in T or B cell subsets in either local lung or systemic 
tissues, either in regards to cell percentages (data not shown) or 
total cells (Table 1A). In a similar manner, no significant differ-
ences were found between percentages or total numbers of CD8+, 
CD4+, or CD19+ lymphocytes in the BAL, ILN, and spleen at 
LIT (Table 1B). However, in the HLN at LIT, Cbl-b−/− mice had 
increased numbers of all lymphocytes analyzed as compared to 
wild-type mice, indicative of an increase in total cellularity of the 
node. This increase was not due to changes in the distribution of 
lymphocyte subsets in the HLN, as percentages of CD8+, CD4+, 
and CD19+ cells were equivalent (data not shown).
During the progression from AAD to LIT in this OVA model, 
the ratio of T cell subsets in the BAL of wild-type mice shows 
a progression from a CD4+ environment (~2:1) to a normal-
ized CD4:CD8 environment (~1:1) (21). In Cbl-b−/− mice, the 
ratio of total CD4:CD8 T cells in the BAL was skewed toward 
CD8+ T cells (~1.5) in comparison to the ratio in wild-type 
mice (~2.2). However, this difference was not apparent for total 
numbers of CD4+ or CD8+ T cells in the BAL when compared 
between wild-type and Cbl-b−/− mice. At LIT, the BAL of 
Cbl-b−/− mice showed a skewed CD4:CD8 T cell ratio (~0.8) 
FigUre 3 | systemic serum OVa-ige levels in wild-type and cbl-b 
mice are increased at aaD. Serum from wild-type or Cbl-b mice was 
isolated at the indicated timepoints and analyzed via OVA-specific IgE ELISA. 
Data represent the mean ± SEM of 6–8 mice per group. *p < 0.05 vs. Naïve/
Sensitized levels.




BAL Wild-type 6.2 ± 2 13.8 ± 5 11.7 ± 9
Cbl-b−/− 15.8 ± 4 23.9 ± 6 10.1 ± 4
HLN Wild-type 61.8 ± 25 79.9 ± 34 159.3 ± 128
Cbl-b−/− 143.3 ± 43 160.2 ± 48 424.7 ± 163
ILN Wild-type 24.2 ± 9 27.9 ± 10 20.4 ± 6
Cbl-b−/− 25.8 ± 7 23.9 ± 6 21.6 ± 7
Spleen Wild-type 171.7 ± 28 303.2 ± 65 169.5 ± 34
Cbl-b−/− 172.5 ± 39 326.3 ± 68 148.3 ± 20
(B) liT
BAL Wild-type 0.9 ± 0.2 1.4 ± 0.2 0.5 ± 0.04
Cbl-b−/− 9.8 ± 5 7.6 ± 4 3.3 ± 1
HLN Wild-type 116.7 ± 37 111.4 ± 28 64.6 ± 1
Cbl-b−/− 291.1 ± 65* 259.9 ± 53* 265.0 ± 43*
ILN Wild-type 41.8 ± 10 44.8 ± 10 7.1 ± 1
Cbl-b−/− 21.1 ± 7 19.7 ± 6 3.2 ± 2
Spleen Wild-type 142.3 ± 53 230.3 ± 74 159.6 ± 74
Cbl-b−/− 171.3 ± 38 232.3 ± 48 310.3 ± 125
Single-cell suspensions of the indicated tissues and tissue compartments were 
analyzed via flow cytometry for the presence of CD8+, CD4+, and CD19+ lymphocytes. 
Total numbers (cells × 104) were obtained as indicated in the Section “Materials and 
Methods.” n = 5–8 mice per group.
*p < 0.05 vs. wild-type.
FigUre 2 | lung histology from wild-type and cbl-b mice. Formalin-
fixed lungs from wild-type or Cbl-b−/− mice at naïve (a,B), AAD (c,D) or LIT 
(e,F) were stained with Hematoxin and Eosin (H&E) for analysis of tissue 
inflammation, and periodic acid-Schiff (PAS) (inserts) for the identification of 
mucus production. All sections at 20× magnification. Scale bar = 100 μm.
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as compared to wild-type mice (~1.5), which was largely due 
to a statistically significant increase in percentages of CD8+ T 
cells (of lymphocytes, 10.3 ± 2.8% for wild-type vs. 23.6 ± 3.0% 
for Cbl-b−/−, p = 0.019). While all lymphocyte subsets analyzed 
were increased in terms of total number in the Cbl-b−/− BAL, 
these differences were not statistically significant, primarily due 
to increased variation in total numbers of lymphocytes in the 
Cbl-b−/− mice.
cbl-b Deficiency Did not result in 
increased OVa-specific ige Production in 
serum
A standard outcome of this OVA-induced model of AAD is the 
production of OVA-specific IgE in the serum, which is a hallmark 
of TH2 allergic responses in both mice and humans. Serum levels 
of OVA-IgE in naïve or sensitized wild-type and Cbl-b−/− mice 
were minimal and showed no significant differences between 
strains (Figure 3). At AAD, both wild-type and Cbl-b−/− exhibited 
elevated serum OVA-IgE levels; however, there were no signifi-
cant differences observed in OVA-IgE concentrations between 
mouse strains (p =  0.38; Figure  3). Similarly, OVA-IgE levels 
remained elevated in both mouse strains at LIT; however, there 
were no significant differences observed between wild-type and 
Cbl-b−/− mice (p = 0.20; Figure 3).
cbl-b−/− Mice exhibited increased levels 
of Proinflammatory cytokines and 
chemokines in the Bal During aaD and 
liT
As the increased airway inflammation in Cbl-b−/− mice during 
AAD and LIT did not correlate with modulations in lymphocyte 
populations in the BAL (Table 1) or increases in systemic OVA-
specific IgE (Figure  3), we sought to determine if increases in 
proinflammatory cytokines in the local lung environment cor-
related with the exacerbation of inflammation in Cbl-b−/− mice. 
BAL proteins from both wild-type and Cbl-b−/− mice at the 
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indicated timepoints were analyzed via multiplex bead assay for 
the presence of numerous proinflammatory cytokines, along 
with the T cell chemotactic factor CCL5 (RANTES) (Figure 4).
No significant differences were observed between wild-type 
and Cbl-b−/− mice at the indicated timepoints for levels of IL-2 
(Figure  4A), IL-4 (Figure  4B), IL-10 (Figure  4E), or IL-12p70 
(Figure 4F). However, Cbl-b−/− mice had increased levels of the 
TH2 cytokines IL-5 (Figure  4C) and IL-13 (Figure  4G), along 
with the proinflammatory cytokine IL-6 (Figure 4D) in the BAL 
at AAD as compared to wild-type. At LIT, Cbl-b−/− mice had 
increased levels of both IL-5 (Figure 4C) and CCL5 (Figure 4H) 
in the BAL as compared to wild-type, while levels of IL-6 and 
IL-13 returned to levels comparable to wild-type. In addition, no 
significant differences were observed in IFNγ levels between wild-
type and Cbl-b−/− mice, as IFNγ was not detected in the BAL at any 
timepoint of the model in either mouse strain (data not shown).
cD4+ cD25+ Foxp3− activated T cells are 
increased in the Bal of cbl-b−/− Mice at 
aaD
To further characterize the CD4+ T cell response in local lung 
vs. systemic tissues during AAD and LIT, CD4+ T cells were 
analyzed for expression of the activation marker CD25 and the 
regulatory T cell-specific transcription factor Foxp3. As with the 
previous lymphocyte characterization, no significant differences 
were found between wild-type and Cbl-b−/− mice for percentages 
of CD4+ CD25+ Foxp3− and CD4+ CD25+ Foxp3+ in systemic 
compartments at all timepoints (data not shown). However, 
Cbl-b−/− mice did exhibit an increase in the Foxp3− population 
in the BAL during AAD, in terms of percentage of the total CD4+ 
population (8.64 ± 0.8% for wild-type vs. 12.6 ± 0.9% for Cbl-
b−/−, n = 5 for each group, p < 0.01) (Figure 5A). When these 
values are expressed as a ratio, the differences in cell composition 
during AAD become apparent, with an increase in Foxp3− in 
Cbl-b−/− mice (Figure 4B). At LIT, this difference was no longer 
apparent, as percentages of Foxp3− and Foxp3+ were equivalent 
between wild-type and Cbl-b−/− mice (4.90 ± 0.9% for wild-type 
vs. 5.86 ± 0.8% for Cbl-b, n = 5 for each group) (Figure 5B).
DiscUssiOn
The role of Cbl-b in the regulation of peripheral T cell responses is 
well documented; however, its role in mediating TH2-type allergic 
responses remains elusive. The results of these studies indicate 
that Cbl-b plays an integral role in regulating the intensity of 
an allergic airway response in mice, as Cbl-b−/− mice exhibit 
increased inflammation during acute and chronic stages of an 
OVA-induced AAD model. This exacerbation does not appear to 
be due to the inherent autoimmune phenotype of Cbl-b−/− mice 
(9), since age-matched (i.e., 18-week) naïve Cbl-b−/− mice did 
not develop airway inflammation. These results indicate that 
Cbl-b deficiency can influence the severity of AAD through the 
dysregulation of T cell responses.
Long-term aerosol exposure in OVA-sensitized mice results in 
the resolution of AAD, characterized by a reversal of eosinophilia 
and mucus secretion in the airways (17, 21). Interestingly, the 
resolution of AAD was inhibited in Cbl-b−/− mice, as these mice 
exhibited persistent eosinophilia and mucus secretion in the 
airways at the chronic stage as compared to wild-type controls. 
Previous reports have indicated that the resolution of AAD in 
wild-type mice is dependent on continuous aerosol exposure 
(17). These results suggest that the inability of Cbl-b−/− mice to 
resolve AAD in response to long-term continuous aerosol expo-
sure may be due to its inability to mount a Treg-mediated local 
inhalational tolerant state, perhaps via the dysfunctional nature 
of Treg interactions in these mice.
Along with histological evidence of increased airway 
inflammation, Cbl-b−/− mice exhibited increased levels of the 
proinflammatory cytokines IL-5, IL-6, and IL-13 in the BAL 
at AAD. Additionally, levels of the TH2 cytokine IL-5 and the 
T cell chemokine CCL5 were increased at LIT above wild-type 
levels, indicating a role for these immune modulating signaling 
proteins in the exacerbation of inflammation during prolonged 
aerosol exposure in Cbl-b−/− mice. IL-5 and IL-13 are TH2 
cytokines associated with the development of airway inflamma-
tion in mice (23) and humans (24, 25); the observed increase in 
these proinflammatory cytokines in Cbl-b−/− mice is suggestive 
of exacerbated TH2 cell responses to aerosol challenge during 
acute inflammation. While the role of IL-6 in allergic inflam-
mation is less clear, it is a potent inflammatory cytokine, and 
has been shown to play a role in fungal-induced asthma (26). 
Additionally, IL-6 has been shown to act as a negative regulatory 
of Treg function (27, 28), suggesting that the increase in IL-6 at 
AAD in Cbl-b−/− may be evidence of “resistance to regulation” 
during acute inflammation through IL-6 mediated inhibition of 
Treg suppression. At LIT, levels of IL-5 were significantly increased 
compared to wild-type, which may provide a mechanism for the 
increased eosinophils in the BAL of Cbl-b−/− mice at LIT, as IL-5 
is a potent chemoattractant and activation factor for eosinophils 
(29, 30). Interestingly, levels of CCL5 in the BAL of Cbl-b−/− mice 
were increased above wild-type levels only at LIT, suggesting that 
increased T cell chemokine expression in Cbl-b−/− mice may play 
a role at exacerbating inflammation at LIT.
Cbl-b−/− effector T cells (Teff) have been shown to be “resistant 
to regulation,” in that they are unresponsive to the suppressive 
effects of either Treg or the immunosuppressive cytokine TGF-β 
both in vitro and in vivo (15, 16). This deficiency in regulation 
is not due to intrinsic defects in Cbl-b−/− Treg, as these cells are 
capable of suppressing wild-type Teff proliferation in  vitro (15). 
However, the ability of naïve Cbl-b−/− Teff to respond to Treg in vivo 
and in vitro is severely impaired (15), suggesting that “resistance 
to regulation” may be due to defects in the cross-talk necessary 
between Teff and Treg for the suppression of inflammation. Treg are 
believed to play an important role in the development and/or 
maintenance of LIT, as Foxp3+ T cells are increased in local lung 
compartments in response to long-term aerosol challenge (19). 
Therefore, increased inflammation in Cbl-b−/− mice may be due 
to defects in regulation of activated T cell-mediated inflammation 
by Treg during the progression from AAD to LIT. Importantly, 
the definition of activated T cell in this model system does 
not address the issue of antigen specificity. Further studies are 
required to determine if the increase in inflammation observed 
in Cbl-b−/− are due to an expansion of OVA-specific T cell subsets, 
FigUre 4 | Proinflammatory cytokines and chemokines were increased in the Bal of cbl-b−/− mice at aaD and liT. Concentrated BAL samples from 
wild-type (C57BL/6) and Cbl-b−/− mice at the indicated timepoints were analyzed via multiplex bead assay for the presence of IL-2 (a), -4 (B), -5 (c), -6 (D), -10 (e), 
-12p70 (F), and -13 (g) along with the T cell chemotactic factor CCL5 (h). Data represent the mean ± SEM of 4–6 mice per group. **p < 0.01, ***p < 0.001, 
****p < 0.0001 vs. wild-type.
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FigUre 5 | Percentage of cD4+ cD25+ Foxp3− T cells are increased in Bal of cbl-b−/− mice during aaD. (a) Representative flow cytometric analysis of 
BAL fluid from wild-type and Cbl-b−/− mice at AAD and LIT. Samples were gated on CD3+ CD4+ T cells. (B) Ratio of BAL T cells at AAD and LIT in wild-type and 
Cbl-b−/− mice. Ratios were obtained by dividing the percentage of CD4+ CD25+ Foxp3− T cells by the percentage of CD4+ CD25+ Foxp3+ T cells. Data represent the 
mean ± SEM of 5 mice per group. *p < 0.05 vs. wild-type.
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enhanced activation of an equivalent population of OVA-specific 
T cells, or some combination of both phenomena.
Cbl-b plays an important role in T cell activation through 
its interaction with signal transduction factors downstream of 
CD28. Additionally, Cbl-b plays a role in regulating Teff function 
after antigen-induced activation through involvement with cell-
intrinsic and cell-to-cell regulatory pathways. In terms of cell-
intrinsic pathways, Cbl-b has been shown to play an important 
role in anergy induction in response to tolerizing signals (31, 
32). For example, T cells from Cbl-b−/− mice exhibit an inability 
to develop anergy in response to calcium ionophore treatment 
in  vitro, and in  vivo antigen challenge of in  vitro anergized 
Cbl-b−/− T cells with cognate antigen results in T cell-mediated 
lethality in recipient mice (33). Calcium-mediated anergy induc-
tion proceeding through calcineurin has also been shown to rely 
on Cbl-b, along with other E3 ubiquitin ligases, as expression of 
Cbl-b was increased in sustained calcium flux-mediated anergic 
T cells (7). Based on these findings, it is possible that the increased 
airway inflammation in Cbl-b−/− mice may be due to a deficiency 
in anergy induction in activated T cells, especially in terms of 
chronic antigen exposure at LIT.
Cbl-b−/− mice in our model exhibited a modulation in the CD4+ 
CD25+ Foxp3− T cell population during AAD as these cells were 
increased as a percentage of the total CD4+ T cell population in 
the BAL as compared to wild-type BAL. This increase in Foxp3− T 
cells in local lung compartments during AAD may be influencing 
the increase in airway inflammation seen in Cbl-b−/− mice. At 
LIT, wild-type and Cbl-b−/− mice had equivalent frequencies of 
Foxp3− and Foxp3+ T cells in the BAL, which appears in contrast 
to the increased airway inflammation seen at LIT in Cbl-b−/− 
mice. However, the inability to resolve airway inflammation in 
Cbl-b−/− mice at LIT may be due to the “resistant to regulation” 
phenotype of Cbl-b−/− T cells and not to enhanced Foxp3− T cell 
populations as seen at AAD. These results suggest that separate 
mechanisms may control the severity of inflammation at AAD 
and LIT, with both involving Cbl-b. For example, the inability of 
Cbl-b−/− T cells to be regulated by Foxp3+ Treg may play a role in 
the expanded Foxp3− activated T cell pool seen at AAD, while a 
combination of resistance to “(extrinsic) regulation” by Treg and 
“(intrinsic) regulation” through anergy induction may result in 
the maintenance of airway inflammation at LIT. Further studies 
are required to assess the functionality of T cell subpopulations 
in the BAL at AAD and LIT in Cbl-b mice, along with the role of 
TGF-β, which has been shown to be induced as a result of OVA 
aerosol challenge in this model (17).
For the most part, the effect of Cbl-b deficiency on the severity of 
inflammation during AAD and LIT did not result in modulations 
in lymphocyte populations. For example, Cbl-b−/− mice did not 
exhibit increases in CD4+ or CD8+ T cells, or CD19+ B cells, in local 
lung or systemic compartments during AAD and LIT, suggesting 
that the exacerbation of inflammation in Cbl-b−/− mice was not 
due to increases in numbers of effector lymphocytes. Interestingly, 
a general increase of total numbers of all lymphocytes analyzed 
was observed in the HLN of Cbl-b−/− mice at LIT. Previous studies 
have indicated that T cells lacking Cbl-b exhibit a hyperprolifera-
tive phenotype in vitro (5, 9), suggesting a possible cause for this 
observed expansion of T cells in this in vivo model. Of additional 
interest is the skewing of the T cell response in Cbl-b−/− mice 
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toward CD8+ T cells, especially in the BAL. Cbl-b−/− mice exhibited 
a decreased CD4:CD8 T cell ratio at both AAD and LIT as com-
pared to wild-type mice, which is unexpected due to the TH2-type 
nature of the OVA-induced AAD response. Little is known about 
the role of Cbl-b in T-helper polarization; however, Cbl-b has been 
indicated in TCR-mediated activation-induced cell death (AICD) 
in TH1 cells (34), and has been shown to play a role in skewing 
thymocyte development toward CD8+ T cells in c-Cbl/Cbl-b 
dual−/− mice (35). These studies provide evidence that dysregulated 
TH1 responses or CD8+ T cell development in Cbl-b−/− mice could 
result in the increase in CD8+ T cells at AAD and LIT.
In addition, Cbl-b has been shown to play an important role in 
negatively regulating B cell receptor (36) and CD40 signal strength 
(37), suggesting a similar mechanism governing the expansion of 
B cells in the HLN of Cbl-b−/− mice during LIT. However, conflict-
ing reports suggest that Cbl-b acts as a positive regulator of B cell 
activation through interactions with TRANCE receptor (38) and 
Erk (39) with downstream effects on calcium mobilization and the 
signal transduction proteins Akt and Lyn. While the expansion of 
B cells in the HLN during LIT appears to correlate with increased 
inflammation in the lungs of Cbl-b−/− mice, it is not cell-specific, 
as all lymphocyte subsets analyzed were increased in the HLN of 
Cbl-b−/− mice at LIT. Similarly, while serum IgE levels were slightly 
elevated in Cbl-b−/− mice as compared to wild-type controls, they 
were not statistically significant. This observation may be explained 
by the observed patterns of cytokine expression observed in this 
animal model. For example, despite elevated production of specific 
TH2 cytokines in Cbl-b−/− mice, such as IL-5 and IL-13, there was 
no significant elevation in IL-4 production observed. As IL-4 is 
the primary TH2 cytokine responsible for IgE class-switching (40), 
the equivalent production of IgE in Cbl-b−/− mice during AAD 
and LIT may be due to the equivalent IL-4 production observed 
concurrently at both timepoints. Regardless, these findings sug-
gest a possible role for B cell dysregulation in Cbl-b−/− mice in this 
model, albeit one that needs to be further elucidated.
Previous work indicates that OVA-induced allergic airway 
inflammation in mice can be induced in B cell deficient mice (41, 
42). However, recent studies have indicated that Cbl-b plays an 
important role in regulating mast cell activation (43) and subse-
quent cytokine production (44) by IgE-activated mast cells, which 
are critical mediators in allergic lung inflammation in both mice 
(45, 46) and humans (47, 48). Therefore, exacerbation of disease in 
Cbl-b−/− mice may be due to a combination of B cell and mast cell 
dysregulation, correlated with IgE crosslinking of FcϵRI during 
aerosol challenge. As discussed previously, Cbl-b has also been 
shown to play important roles in mediating anergy induction in 
other lymphoid subsets in addition to B cells and mast cells, such 
as NK and NK-T cells. In the experimental animal model utilized 
in this study (Cbl-b−/−), all leukocyte subsets are deficient in Cbl-b 
expression, meaning that there is probably a pleiotropic effect of 
Cbl-b deficiency on global cellular immune responses in this 
inhaled allergy model. Further studies are required to assess the 
contribution of Cbl-b deficiency on the function of other immune 
cell subsets in the context of OVA-induced AAD and LIT.
In conclusion, Cbl-b−/− mice exhibit increased inflammatory 
responses to OVA-induced allergic airway inflammation, includ-
ing exacerbations in disease outcomes at both AAD and LIT 
timepoints, and increases in T cell chemokine and proinflamma-
tory TH2 cytokines in the BAL. Conversely, Cbl-b−/− mice did not 
show modulations in T or B cells in local or systemic compart-
ments during AAD or LIT, nor was there a significant modulation 
in serum IgE production at either timepoint. Finally, Cbl-b did 
exhibit a increase in a possibly polyclonal cell population with 
an effector T cell phenotype in the BAL during AAD, suggesting 
a dysregulation of T cell responses during acute disease. These 
findings indicate a role for Cbl-b in the regulation and resolution 
of allergic airway responses, along with suggesting a correlation 
between disease severity and impaired regulatory T cell functions.
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